Functional genomics in sarcoidosis--reduced or increased apoptosis?
D000208:Acute Disease; D000328:Adult; D017209:Apoptosis / Q000235:genetics* / Q000502:physiology*; D020169:Caspases / Q000235:genetics / Q000502:physiology; D016207:Cytokines / Q000235:genetics / Q000502:physiology; D005260:Female; D020869:Gene Expression Profiling; D019254:Genes, bcl-2 / Q000235:genetics / Q000502:physiology; D016158:Genes, p53 / Q000235:genetics / Q000502:physiology; D023281:Genomics; D006133:Growth Substances / Q000235:genetics / Q000502:physiology; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000502:physiology; D008297:Male; D008875:Middle Aged; D020411:Oligonucleotide Array Sequence Analysis; D011446:Prospective Studies; D017565:Sarcoidosis, Pulmonary / Q000235:genetics* / Q000503:physiopathology*; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000502:physiology